Lantern Pharma Receives EMA Clearance for Phase 1b/2 Trial of LP-184 in Bladder Cancer

Lantern Pharma announced EMA approval for a biomarker-guided trial of LP-184 in advanced bladder cancer, potentially offering a new treatment option f...